 has agreed to pay $600 million){kind=link}
New Delhi, July 3, 2026: In a major development in cross-border corporate insolvency, India’s state-owned Bank of Baroda (BoB) has agreed to pay $600 million (approximately ₹5,700 crore) to settle its high-stakes, multi-jurisdictional legal battle with the collapsed UAE-based healthcare giant, NMC Health, and its joint administrators.
The out-of-court settlement, disclosed by the lender in a regulatory filing with Indian stock exchanges on July 2, 2026, effectively caps the bank’s potential liability and brings an end to complex fraud and insolvency proceedings that have spanned courts in both Abu Dhabi and London for years. The massive payout was executed directly through the bank’s Abu Dhabi branch.
The Roots of the Dispute: The Fall of NMC Health
To understand the scale of this settlement, one must look back to the dramatic collapse of NMC Health in late 2019 and early 2020. Founded by Indian-born billionaire entrepreneur Dr. B.R. Shetty, NMC Health was once the largest private healthcare provider in the United Arab Emirates. It achieved massive global status, listing on the prestigious London Stock Exchange and entering the blue-chip FTSE 100 index in 2017, reaching a peak valuation of around £8.6 billion ($11 billion).
However, the empire unraveled at lightning speed in December 2019 after the short-selling firm Muddy Waters published a damning report. The report alleged widespread financial irregularities, including drastically inflated assets and undisclosed related-party transactions. A subsequent independent forensic audit shocked the global financial community by uncovering $4 billion to $6 billion in hidden debt.
The revelation proved fatal. With $6.6 billion in total debt liabilities completely overwhelming its books, NMC Health fell into severe financial distress, destroying investor confidence and leaving a massive trail of losses for major Middle Eastern and international lenders. The group officially entered administration in 2020 under the stewardship of joint administrators Richard Fleming, Benjamin Cairns, and Mark Firmin.
Why Bank of Baroda Was Caught in the Crosshairs
Bank of Baroda was initially involved with the healthcare conglomerate as a traditional lender, having extended an estimated credit exposure of $250 million to NMC Health and Dr. B.R. Shetty. However, the legal battle quickly morphed from a standard loan recovery process into an aggressive offensive by NMC Health’s joint administrators.
The administrators initiated parallel legal actions across two major global financial jurisdictions:
- The ADGM Proceedings: Filed before the Abu Dhabi Global Market Court of First Instance.
- The English Proceedings: Filed before the High Court of Justice, England & Wales.
The core of the administrators’ case rested on serious allegations regarding Bank of Baroda’s lending practices. They contended that the bank’s financial arrangements and credit extensions actively facilitated or prolonged the fraud. Specifically, it was alleged that the bank processed or extended credit facilities backed by fictitious invoices and undisclosed borrowings. According to the lawsuits, these arrangements allowed NMC Health’s management to systematically conceal the true state of their debt and continue bleeding the company while keeping creditors in the dark.
By pulling Bank of Baroda into the litigation, the administrators aimed to reclaim funds from the bank to expand the financial pool available to pay back thousands of other harmed creditors, bondholders, and trade suppliers.
Breaking Down the Out-of-Court Settlement
The dispute had entered a critical phase in 2026. The trial before the ADGM courts in Abu Dhabi had formally commenced on March 23, 2026, while the English court proceedings had been put on temporary hold waiting for the Abu Dhabi verdict. Facing the prospect of an exhausting, highly publicized, and unpredictable multi-year trial, Bank of Baroda opted to negotiate a resolution.
According to the exchange filings, the $600 million agreement ensures a clean break for the Indian public sector lender. The most crucial aspect of the deal for Bank of Baroda is the strict non-admission clause. The bank explicitly stated that the parties reached the settlement without any admission of liability, fault, or wrongdoing by either side.
With the execution of this pact, both the active trial in Abu Dhabi and the frozen proceedings in London are being permanently discontinued and withdrawn, eliminating any future legal risk tied to the NMC saga.
Financial Impact and Market Reaction
While the massive $600 million payout provides legal certainty, it represents an undeniable financial blow to Bank of Baroda’s immediate quarterly balance sheet.
To put the ₹5,700 crore settlement into context, it is roughly equivalent to the bank’s entire net profit for the January–March quarter of the previous financial year (FY26), which stood at ₹5,616 crore. However, banking analysts note that the lender’s overarching capital position remains remarkably sturdy. For the full financial year, Bank of Baroda posted an impressive net profit of ₹20,021 crore.
The ultimate hit to the bank’s upcoming earnings report will largely depend on its prior provisioning strategies. If the bank had already set aside substantial provisions against its NMC litigation risk over the past few years, the accounting impact on future profits will be relatively cushioned. However, if the settlement requires a fresh, unprovisioned charge, it will mark a heavy one-time hit.
The stock market reacted swiftly to the corporate filing. Shares of Bank of Baroda fell by over 4%, closing at ₹260.15 on the National Stock Exchange (NSE) on the day of the announcement, reflecting immediate investor anxiety regarding the short-term cash outflow.
Despite the stock drop, market experts view the decision as a pragmatic corporate maneuver. In complex cross-border banking fraud cases, settling often serves as the most effective strategy to cap systemic downside risk, avoid skyrocketing international legal fees, and redirect management’s focus back toward core commercial operations. Crucially, the bank’s underlying fundamentals remain strong, with its domestic deposits growing at 14.7% to ₹14.2 lakh crore and domestic advances rising 16.1% to ₹11.5 lakh crore in the latest tracking period.